ArticleMolecular therapy : the journal of the American Society of Gene Therapy2017

Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.

Florie Borel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.